| Abstract: | We have described a novel use of the D4G prodrug (Cyclo-D4G) approach to stabilize the nucleoside and maintain the anti-HIV activity. β-D-Dioxolanyl-2-amino-6-cyclopropylaminopurine (10, DACP) was synthesized as a prodrug of β-D-dioxolanyl guanine (DXG) and showed potent anti-HIV activity in vitro (EC50=0.18 μmol·L-1 The pharmacokinetics of Cyclo-D4G and DACP following intravenous and oral administration of DACP to rhesusmonkeys and rats did not give D4G and DXG as detectable metabolic products by HPLC. Therefore the radio labeled Cyclo-D4G and DACP are necessary for the pharmacokinetics studies in detail. |
